Efficacy and safety of zanubrutinib versus rituximab-based chemoimmunotherapy in Waldenström macroglobulinemia (WM): Matching-adjusted indirect comparisons: Hematologic malignancies—lymphoma and chronic lymphocytic leukemia

Jorge J Castillo, Keri Yang, Rongzhe Liu, Yu Wang, Aileen Cohen, Todd M Zimmerman, Qian Zhao, Xin Gao, Boxiong Tang

Research output: Contribution to journalMeeting abstract


Meeting Abstract | 2021 ASCO Annual Meeting I
Original languageEnglish
Pages (from-to)7559
Number of pages1
JournalJournal of Clinical Oncology
Issue number15 supplement
Publication statusPublished - 2021

Cite this